These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6455792)

  • 1. Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells.
    Pollack MS; Kapoor N; Sorell M; Morishima Y; Dupont B; O'Reilly RJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):270-2. PubMed ID: 6455792
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
    Pollack MS; Kirkpatrick D; Kapoor N; Dupont B; O'Reilly RJ
    N Engl J Med; 1982 Sep; 307(11):662-6. PubMed ID: 7050708
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone marrow transplanation for severe combined immunodeficiency with the HL-A-incompatible but MLC-identical mother as a donor.
    Neithammer D; Goldmann SF; Haas RJ; Dietrich M; Flad HD; Fliedner TM; Kleihauer E
    Transplant Proc; 1976 Dec; 8(4):623-8. PubMed ID: 11594
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency.
    Thompson LF; O'Connor RD; Bastian JF
    J Immunol; 1984 Nov; 133(5):2513-7. PubMed ID: 6090535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mixed lymphocyte culture as a compatibility test for bone marrow transplantation].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1986 Jan; 98(2):44-9. PubMed ID: 2938340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of T cell culture techniques to establish the presence of an intrauterine-derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID).
    Flomenberg N; Dupont B; O'Reilly RJ; Hayward A; Pollack MS
    Transplantation; 1983 Dec; 36(6):733-5. PubMed ID: 6606881
    [No Abstract]   [Full Text] [Related]  

  • 9. DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease.
    Pollack MS; Kapoor N; Sorell M; Kim SJ; Christiansen FT; Silver DM; Dupont B; O'Reilly RJ
    Transplantation; 1980 Nov; 30(5):331-4. PubMed ID: 6450472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
    O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
    [No Abstract]   [Full Text] [Related]  

  • 11. Transplantation of a patient with severe combined immunodeficiency (SCID) with bone marrow from the MLC identical donor: some immunobiological aspects [proceedings].
    Flad HD; Stein G; Haas RJ; Niethammer D; Goldmann SF; Dietrich M
    Z Immunitatsforsch Immunobiol; 1976 Dec; 152(4):330-4. PubMed ID: 137603
    [No Abstract]   [Full Text] [Related]  

  • 12. Probable role of suppressor cells and factors in kidney graft survival.
    Bensussan A; Klatzmann D; Gluckman JC; Kalil J; Dausset J; Sasportes M
    Transplant Proc; 1982 Sep; 14(3):584-7. PubMed ID: 6217608
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of circulating maternal T and B lymphocytes in uncomplicated severe combined immunodeficiency by HLA typing of subpopulations of T cells separated by the fluorescence-activated cell sorter and of Epstein Barr virus-derived B cell lines.
    Geha RS; Reinherz E
    J Immunol; 1983 Jun; 130(6):2493-5. PubMed ID: 6304187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenetic composition of 94 consecutive Danish families investigated with respect to bone marrow transplantation.
    Christiansen SE; Jørgensen F; Kristensen T; Lamm LU; Hansen PW; Kissmeyer-Nielsen F
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):239-44. PubMed ID: 2939600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency.
    Bonduel M; Pozo A; Zelazko M; Raslawski E; Delfino S; Rossi J; Figueroa C; Sackmann Muriel F
    Bone Marrow Transplant; 1999 Aug; 24(4):437-40. PubMed ID: 10467337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA typing and karyotyping of limited numbers of lymphocytes is facilitated by in vitro expansion with TCGF.
    Blank JL; Hank JA; Molenda J; Borcherding W; Meisner L; Sondel PM
    Diagn Immunol; 1985; 3(1):29-32. PubMed ID: 3888497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic reconstitution in severe combined immunodeficiency with HL-A-incompatible bone marrow graft: donor selection by mixed lymphocyte culture.
    Dupont B; Andersen V; Ernst P; Faber V; Good RA; Hansen GS; Henriksen K; Jensen K; Juhl F; Killmann SA; Koch C; Muller-Berat N; Park BH; Svejgaard A; Thomsen M; Wiik A
    Transplant Proc; 1973 Mar; 5(1):905-8. PubMed ID: 4144470
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.
    O'Reilly RJ; Kirkpatrick D; Kapoor N; Collins N; Brochstein J; Kernan N; Flomenberg N; Pollack M; Dupont B; Lopez C
    Prog Clin Biol Res; 1985; 193():327-42. PubMed ID: 3911216
    [No Abstract]   [Full Text] [Related]  

  • 20. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.